BSGM (BioSig Technologies) Days Sales Outstanding : 0.00 (As of Mar. 2025)

View and export this data going back to 2014. Start your Free Trial

What is BioSig Technologies Days Sales Outstanding?

BioSig Technologies's average Accounts Receivable for the three months ended in Mar. 2025 was $0.11 Mil. BioSig Technologies's Revenue for the three months ended in Mar. 2025 was $0.00 Mil.

The historical rank and industry rank for BioSig Technologies's Days Sales Outstanding or its related term are showing as below:

BSGM' s Days Sales Outstanding Range Over the Past 10 Years
Min: 11.49 Med: 334.58 Max: 1030.42
Current: 1030.42

During the past 12 years, BioSig Technologies's highest Days Sales Outstanding was 1030.42. The lowest was 11.49. And the median was 334.58.

BSGM's Days Sales Outstanding is ranked worse than
99.14% of 810 companies
in the Medical Devices & Instruments industry
Industry Median: 65.905 vs BSGM: 1030.42

BioSig Technologies's Days Sales Outstanding declined from Mar. 2024 (123.84) to Mar. 2025 (0.00).

BioSig Technologies Days Sales Outstanding Historical Data

The historical data trend for BioSig Technologies's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioSig Technologies Days Sales Outstanding Chart

BioSig Technologies Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Sales Outstanding

Get a 7-Day Free Trial

11.49

334.58

606.81

BioSig Technologies Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Days Sales Outstanding	Get a 7-Day Free Trial															123.84	238.65	-	666.83	-

Competitive Comparison of BioSig Technologies's Days Sales Outstanding

For the Medical Devices subindustry, BioSig Technologies's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioSig Technologies's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BioSig Technologies's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where BioSig Technologies's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

BioSig Technologies Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

BioSig Technologies's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

	Days Sales Outstanding (A: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (0.024	+	0.109)	/	2 )	/	0.04	*	365
=	0.0665					/	0.04	*	365
=	606.81

BioSig Technologies's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding (Q: Mar. 2025 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2024 )	+	Accounts Receivable (A: Mar. 2025 ))	/	count )	/	Revenue (A: Mar. 2025 )	*	Days in Period
=	( (0.109	+	0.109)	/	2 )	/	0	*	365 / 4
=	0.109					/	0	*	365 / 4
=	N/A

BioSig Technologies (NAS:BSGM) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

BioSig Technologies Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of BioSig Technologies's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

BioSig Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BioSig Technologies Inc (NAS:BSGM) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

12424 Wilshire Boulevard, Suite 745, Los Angeles, CA, USA, 90025

Website

https://www.biosig.com

BioSig Technologies Inc is a medical device technology company with an advanced digital signal processing technology platform, the PURE EP Platform (PURE EP), that delivers insights to electrophysiologists for ablation treatments of cardiovascular arrhythmias. The PURE EP Platform enables electrophysiologists to acquire raw signal data in real-time, absent unnecessary noise or interference, to maximize procedural success and minimize unnecessary inefficiencies.

Executives

Kenneth L Londoner	director, 10 percent owner	10 RED COAT ROAD, WESTPORT CT 06880
Steven J Buhaly	officer: Chief Financial Officer	1195 NW LOMPTON DRIVE, BEAVESTON OR 97006
John Sieckhaus	officer: Chief Operating Officer	C/O BIOSIG TECHNOLOGIES, 55 GREENS FARMS ROAD, WESTPORT CT 06880
Steve Chaussy	officer: Chief Financial Officer	9780 E AVE, HESPERIA CA 92345
Patrick Joseph Gallagher	director	275 PLEASANT HILL RD., FLANDERS NJ 07836
Gray Fleming	officer: Chief Commercial Officer	C/O BIOSIG TECHNOLOGIES, INC., 55 GREENS FARMS ROAD, WESTPORT CT 06880
James L Klein	director	2300NE BROOKWOOD PKWY, HILLSBORO OR 97124
Frederick Hrkac	director	C/O BIOSIG TECHNOLOGIES, 55 GREENS FARMS ROAD, WESTPORT CT 06880
James J Barry	director	C/O INSPIREMD, INC., 4 MENORAT HAMAOR ST., TEL AVIV L3 6744832
Jeffrey F Odonnell	director	126 ROSSMORE DRIVE, MALVERN PA 19355
Anthony P. Zook	director	C/O VIVUS, INC., 351 EAST EVELYN AVENUE, MOUNTAIN VIEW CA 94041
Jerome B Zeldis	director	8767 E. VIA DE VENTURA, SUITE 190, SCOTTSDALE AZ 85258
Martha Pease	director	33 SEAVIEW, MADISON CT 06443
John M Kowalski	officer: VP of Sales	54 WILTON ROAD, 2ND FLOOR, WESTPORT CT 06880
Samuel E Navarro	director	C/O STRATA SKIN SCIENCES, INC., 5 WALNUT GROVE DRIVE, SUITE 140, HORSHAM PA 19044